Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Ethical climate and intention to leave among critical care clinicians: an observational study in 68 intensive care units across Europe and the United States.

Van den Bulcke B, Metaxa V, Reyners AK, Rusinova K, Jensen HI, Malmgren J, Darmon M, Talmor D, Meert AP, Cancelliere L, Zubek L, Maia P, Michalsen A, Kompanje EJO, Vlerick P, Roels J, Vansteelandt S, Decruyenaere J, Azoulay E, Vanheule S, Piers R, Benoit D; DISPROPRICUS study group of the Ethics Section of the ESICM.

Intensive Care Med. 2019 Nov 5. doi: 10.1007/s00134-019-05829-1. [Epub ahead of print]

PMID:
31690968
2.

Direct admission to the intensive care unit from the emergency department and mortality in critically ill hematology patients.

Peyrony O, Chevret S, Meert AP, Perez P, Kouatchet A, Pène F, Mokart D, Lemiale V, Demoule A, Nyunga M, Bruneel F, Lebert C, Benoit D, Mirouse A, Azoulay E.

Ann Intensive Care. 2019 Oct 2;9(1):110. doi: 10.1186/s13613-019-0587-7.

3.

Bullous Lupus Under Nivolumab Treatment for Lung Cancer: A Case Report With Systematic Literature Review.

Wouters A, Durieux V, Kolivras A, Meert AP, Sculier JP.

Anticancer Res. 2019 Jun;39(6):3003-3008. doi: 10.21873/anticanres.13432.

PMID:
31177141
4.

Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy.

Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, Rello J, van de Louw A, Klouche K, Meert AP, Martin-Loeches I, Marsh B, Socias Crespi L, Moreno-Gonzalez G, Buchtele N, Amrein K, Balik M, Antonelli M, Nyunga M, Barratt-Due A, Bergmans DCJJ, Spoelstra-de Man AME, Kuitunen A, Wallet F, Seguin A, Metaxa V, Lemiale V, Burghi G, Demoule A, Karvunidis T, Cotoia A, Klepstad P, Møller AM, Mokart D, Azoulay E; Efraim investigators and the Nine-I study group.

Eur Respir J. 2019 Jul 25;54(1). pii: 1802442. doi: 10.1183/13993003.02442-2018. Print 2019 Jul.

PMID:
31109985
5.

[Lung cancer: Prognosis in intensive care depends mainly on the acute complication].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2019 Mar;36(3):333-341. doi: 10.1016/j.rmr.2018.05.014. Epub 2019 Mar 18. French.

PMID:
30898468
6.

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Lemiale V, Meert AP, Vincent F, Darmon M, Bauer PR, Van de Louw A, Azoulay E; Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (Grrr-OH).

Ann Intensive Care. 2019 Feb 1;9(1):25. doi: 10.1186/s13613-019-0487-x. Review.

7.

Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study.

Ehooman F, Biard L, Lemiale V, Contou D, de Prost N, Mokart D, Pène F, Kouatchet A, Mayaux J, Demoule A, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Azoulay E, Zafrani L.

Ann Intensive Care. 2019 Jan 5;9(1):2. doi: 10.1186/s13613-018-0478-3.

8.

Systemic treatments for thymoma and thymic carcinoma: A systematic review.

Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N.

Lung Cancer. 2018 Dec;126:25-31. doi: 10.1016/j.lungcan.2018.10.018. Epub 2018 Oct 18. Review.

PMID:
30527189
9.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Scherpereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
10.

Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies.

Mignard X, Biard L, Lemiale V, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Azoulay E, Zafrani L.

Leuk Lymphoma. 2019 May;60(5):1156-1163. doi: 10.1080/10428194.2018.1516874. Epub 2018 Oct 2.

PMID:
30277108
11.

Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients.

Legoff J, Zucman N, Lemiale V, Mokart D, Pène F, Lambert J, Kouatchet A, Demoule A, Vincent F, Nyunga M, Bruneel F, Contejean A, Mercier-Delarue S, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Schwebel C, Jourdain M, Darmon M, Resche-Rigon M, Azoulay E.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):518-528. doi: 10.1164/rccm.201804-0681OC.

PMID:
30230909
12.

Management of Acute Complications of Targeted Therapy in Patients With Cancer: A Review of Cases Managed in ICU.

Pistone A, Durieux V, Grigoriu B, Meert AP.

J Intensive Care Med. 2019 Jun;34(6):435-448. doi: 10.1177/0885066618787788. Epub 2018 Aug 30.

PMID:
30165779
13.

Outcome in patients perceived as receiving excessive care across different ethical climates: a prospective study in 68 intensive care units in Europe and the USA.

Benoit DD, Jensen HI, Malmgren J, Metaxa V, Reyners AK, Darmon M, Rusinova K, Talmor D, Meert AP, Cancelliere L, Zubek L, Maia P, Michalsen A, Vanheule S, Kompanje EJO, Decruyenaere J, Vandenberghe S, Vansteelandt S, Gadeyne B, Van den Bulcke B, Azoulay E, Piers RD; DISPROPRICUS study group of the Ethics Section of the European Society of Intensive Care Medicine.

Intensive Care Med. 2018 Jul;44(7):1039-1049. doi: 10.1007/s00134-018-5231-8. Epub 2018 May 28.

14.

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P.

Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31.

PMID:
29496253
15.

Ethical decision-making climate in the ICU: theoretical framework and validation of a self-assessment tool.

Van den Bulcke B, Piers R, Jensen HI, Malmgren J, Metaxa V, Reyners AK, Darmon M, Rusinova K, Talmor D, Meert AP, Cancelliere L, Zubek L, Maia P, Michalsen A, Decruyenaere J, Kompanje EJO, Azoulay E, Meganck R, Van de Sompel A, Vansteelandt S, Vlerick P, Vanheule S, Benoit DD.

BMJ Qual Saf. 2018 Oct;27(10):781-789. doi: 10.1136/bmjqs-2017-007390. Epub 2018 Feb 23.

PMID:
29475979
16.

Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic Malignancy.

Zafrani L, Resche-Rigon M, De Freitas Caires N, Gaudet A, Mathieu D, Parmentier-Decrucq E, Lemiale V, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, N'yunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Darmon M, Azoulay E.

Crit Care Med. 2018 Mar;46(3):e250-e257. doi: 10.1097/CCM.0000000000002934.

PMID:
29474336
17.

Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.

Costantini A, Grynovska M, Lucibello F, Moisés J, Pagès F, Tsao MS, Shepherd FA, Bouchaab H, Garassino M, Aerts JGJV, Mazières J, Mondini M, Berghmans T, Meert AP, Cadranel J.

Eur Respir J. 2018 Feb 14;51(2). pii: 1702072. doi: 10.1183/13993003.02072-2017. Print 2018 Feb.

18.

[Impact of routine brain imaging in the initial management of lung cancer].

Niviere P, Sculier JP, Meert AP, Berghmans T.

Rev Mal Respir. 2018 Jan;35(1):55-61. doi: 10.1016/j.rmr.2017.11.004. Epub 2018 Feb 4. French.

PMID:
29397303
19.

[Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma].

Berghmans T, Grigoriu B, Sculier JP, Meert AP.

Rev Mal Respir. 2018 Feb;35(2):197-205. doi: 10.1016/j.rmr.2017.11.007. Epub 2018 Feb 1. Review. French.

PMID:
29395567
20.

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP).

Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017.

21.

Determinants of 1-year survival in critically ill acute leukemia patients: a GRRR-OH study.

Tavares M, Lemiale V, Mokart D, Pène F, Lengliné E, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Darmon M, Azoulay E.

Leuk Lymphoma. 2018 Jun;59(6):1323-1331. doi: 10.1080/10428194.2017.1375106. Epub 2017 Sep 13.

PMID:
28901791
22.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions.

Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J, Sideris S, Holbrechts S, Lafitte JJ, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Sep;111:164-175. doi: 10.1016/j.lungcan.2017.07.026. Epub 2017 Jul 24. Review.

PMID:
28838389
23.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles.

Ruelle L, Bentea G, Sideris S, El Koulali M, Holbrechts S, Lafitte JJ, Grigoriu B, Sculier C, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Sep;111:150-163. doi: 10.1016/j.lungcan.2017.07.025. Epub 2017 Jul 25. Review.

PMID:
28838388
24.

The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Azoulay E, Schellongowski P, Darmon M, Bauer PR, Benoit D, Depuydt P, Divatia JV, Lemiale V, van Vliet M, Meert AP, Mokart D, Pastores SM, Perner A, Pène F, Pickkers P, Puxty KA, Vincent F, Salluh J, Soubani AO, Antonelli M, Staudinger T, von Bergwelt-Baildon M, Soares M.

Intensive Care Med. 2017 Sep;43(9):1366-1382. doi: 10.1007/s00134-017-4884-z. Epub 2017 Jul 19. Review.

PMID:
28725926
25.

[Immunotherapy and non-small cell lung cancer : a (r)evolution].

Berghmans T, Meert AP.

Rev Med Brux. 2017;38(3):175-177. French.

PMID:
28653522
26.

[Dyspnea and cardia cancer, an unusual etiology].

Speybrouck S, Claeys L, Hendlisz A, Meert AP.

Rev Med Brux. 2017;38(3):162-168. French.

PMID:
28653519
27.

Red blood cell transfusion in the resuscitation of septic patients with hematological malignancies.

Mirouse A, Resche-Rigon M, Lemiale V, Mokart D, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Azoulay E, Pène F; Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (Grrr-OH).

Ann Intensive Care. 2017 Dec;7(1):62. doi: 10.1186/s13613-017-0292-3. Epub 2017 Jun 12.

28.

Intensive care in thoracic oncology.

Meert AP, Grigoriu B, Licker M, Van Schil PE, Berghmans T.

Eur Respir J. 2017 May 11;49(5). pii: 1602189. doi: 10.1183/13993003.02189-2016. Print 2017 May. Review.

29.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 2: Hematologic, cutaneous and vascular syndromes.

Holbrechts S, Gorham J, Sideris S, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:93-101. doi: 10.1016/j.lungcan.2017.01.016. Epub 2017 Jan 30. Review.

PMID:
28285701
30.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system.

Bentea G, Sculier C, Grigoriu B, Meert AP, Durieux V, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:83-92. doi: 10.1016/j.lungcan.2017.01.017. Epub 2017 Jan 30. Review.

PMID:
28285700
31.

Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature.

Durieux V, Coureau M, Meert AP, Berghmans T, Sculier JP.

Lung Cancer. 2017 Apr;106:102-109. doi: 10.1016/j.lungcan.2017.01.015. Epub 2017 Jan 30. Review.

PMID:
28285683
32.

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu BD, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP.

Breathe (Sheff). 2016 Sep;12(3):249-255. doi: 10.1183/20734735.009116. Review.

33.

Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome.

Neuschwander A, Lemiale V, Darmon M, Pène F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Mokart D, Azoulay E; A Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (GRRR-OH) study.

J Crit Care. 2017 Apr;38:295-299. doi: 10.1016/j.jcrc.2016.11.042. Epub 2016 Dec 7.

PMID:
28038339
34.

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Destrebecq V, Lieveke A, Berghmans T, Paesmans M, Sculier JP, Meert AP.

Front Med (Lausanne). 2016 Oct 31;3:50. eCollection 2016.

35.

Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study.

Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E.

Ann Intensive Care. 2016 Dec;6(1):102. doi: 10.1186/s13613-016-0202-0. Epub 2016 Oct 25.

36.

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

Berghmans T, Lafitte JJ, Scherpereel A, Ameye L, Paesmans M, Meert AP, Colinet B, Tulippe C, Willems L, Leclercq N, Sculier JP; European Lung Cancer Working Party.

ERJ Open Res. 2015 Oct 19;1(2). pii: 00029-2015. eCollection 2015 Oct.

37.

High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.

Lemiale V, Resche-Rigon M, Mokart D, Pène F, Argaud L, Mayaux J, Guitton C, Rabbat A, Girault C, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Seguin A, Klouche K, Colin G, Kontar L, Perez P, Meert AP, Benoit DD, Papazian L, Demoule A, Chevret S, Azoulay E.

Crit Care Med. 2017 Mar;45(3):e274-e280. doi: 10.1097/CCM.0000000000002085.

PMID:
27655324
38.

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.

Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. Review.

39.

The thoracic oncology specialist: curriculum recommendations in thoracic oncology training.

Meert AP, Noël JL, Gamarra F; Thoracic Oncology HERMES Task Force.

Eur Respir J. 2016 Sep;48(3):628-31. doi: 10.1183/13993003.01069-2016. No abstract available.

40.

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment.

Fischler R, Meert AP, Sculier JP, Berghmans T.

Front Med (Lausanne). 2016 Aug 3;3:33. doi: 10.3389/fmed.2016.00033. eCollection 2016.

41.

[A 38 years old female with inflammatory myofibroblastic tumor and lactic acidosis].

Gorham J, Liberale G, Haydar HN, De Saint Aubain N, Meert AP.

Rev Med Brux. 2016 Mar-Apr;37(2):104-7. French.

PMID:
27487696
42.

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

De Grève J, Van Meerbeeck J, Vansteenkiste JF, Decoster L, Meert AP, Vuylsteke P, Focan C, Canon JL, Humblet Y, Berchem G, Colinet B, Galdermans D, Bosquée L, Vermeij J, Dewaele A, Geers C, Schallier D, Teugels E.

PLoS One. 2016 Mar 31;11(3):e0147599. doi: 10.1371/journal.pone.0147599. eCollection 2016.

43.

Inequalities in lung cancer: a world of EGFR.

Carbonnaux M, Souquet PJ, Meert AP, Scherpereel A, Peters M, Couraud S.

Eur Respir J. 2016 May;47(5):1502-9. doi: 10.1183/13993003.01157-2015. Epub 2016 Mar 30.

44.

[The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2016 Nov;33(9):759-765. doi: 10.1016/j.rmr.2016.02.004. Epub 2016 Mar 24. French.

PMID:
27017064
45.

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.

Azoulay E, Guigue N, Darmon M, Mokart D, Lemiale V, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Bretagne S, Lebert C, Meert AP, Benoit D, Pene F.

Oncotarget. 2016 Apr 19;7(16):21484-95. doi: 10.18632/oncotarget.7471.

46.

[Difficulties and limitations in conducting translational research in thoracic oncology. A practical example].

Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):594-9. doi: 10.1016/j.rmr.2015.10.744. Epub 2016 Jan 6. French.

PMID:
26777111
47.

[Oncological intensive care: 2013 and 2014 years'review].

Sculier JP, Bucalau AM, Closset C, Compagnie M, Gorham J, Sideris S, De Roodebeek DT, Wang XX, Berghmans T, Meert AP.

Rev Med Brux. 2016;37(3):159-167. Review. French.

PMID:
28525189
48.

[Implementation of an oncological care program in a multidisciplinary clinic].

Sculier JP, Leclercq N, Meert AP, Paesmans M, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):600-6. doi: 10.1016/j.rmr.2015.10.741. Epub 2015 Nov 21. French.

PMID:
26611198
49.

Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie.

Darmon M, Vincent F, Canet E, Mokart D, Pène F, Kouatchet A, Mayaux J, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Schlemmer B, Chevret S, Lemiale V, Azoulay E.

Nephrol Dial Transplant. 2015 Dec;30(12):2006-13. doi: 10.1093/ndt/gfv372.

50.

Targeted therapy for lung cancer.

Meert AP, Cadranel J.

Eur Respir J. 2015 Nov;46(5):1239-41. doi: 10.1183/13993003.00812-2015. No abstract available.

Supplemental Content

Support Center